IUPHAR review: Drug repurposing in Schizophrenia – An updated review of clinical trials
There is an urgent need for mechanistically novel and more efficacious treatments for schizophrenia, especially those targeting negative and cognitive symptoms with a more favorable side-effect profile. Drug repurposing—the process of identifying new therapeutic uses for already approved compounds—o...
Saved in:
Main Authors: | Jihan K. Zaki, Jakub Tomasik, Sabine Bahn |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661825000581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
by: Letizia Biso, et al.
Published: (2025-01-01) -
IUPHAR Review: Alpha6-containing GABAA receptors – Novel targets for the treatment of schizophrenia
by: Lih-Chu Chiou, et al.
Published: (2025-03-01) -
Comprehensive evaluation of pure and hybrid collaborative filtering in drug repurposing
by: Clémence Réda, et al.
Published: (2025-01-01) -
Drug repurposing screen for the rare disease ataxia-telangiectasia
by: Namrata Jayanth, et al.
Published: (2025-01-01) -
Publication of studies registered in Clinical Trials Registry of India: An audit of mood disorder research protocols from 2009-2019
by: Vikas Menon, et al.
Published: (2023-01-01)